Imagine your TAKHZYRO
EXPERIENCE

Join more than 4000 people since 2018* who have chosen to help prevent hereditary angioedema (HAE) attacks before they happen.

Want to talk about TAKHZYRO with
your doctor?

CONVERSATION STARTER

*Based on third-party US specialty pharmacy data.
imageoverlay

Dennis

His TAKHZYRO experience started in 2018

Long-term prevention starts here

TAKHZYRO was evaluated in one of the largest prevention studies in HAE.

EXPLORE STUDY RESULTS

SELECT IMPORTANT SAFETY INFORMATION
TAKHZYRO may cause serious side effects, including allergic reactions.

style
color-block-background-rightside, image left, section-no-top-margin, section-no-bottom-margin, section-no-bottom-padding
imageoverlay

Dennis

Real TAKHZYRO patient

id
longterm-prevention

Discover what HAE is

From symptoms to how it impacts day-to-day life

LEARN ABOUT HAE

Want freedom from daily dosing?

Learn how to take TAKHZYRO every 2 weeks for patients 12 years and up

EXPLORE DOSING

Real patients, real stories

Hear from real patients like you

WATCH NOW

Style
Inner-content-contained, home-more-into-columns, section-no-top-margin, section-no-bottom-margin

Supporting HAE patients for over 16 years

Takeda Patient Support helps people who have been prescribed TAKHZYRO per the approved indication get access to their medication.

GET THE DETAILS

Style
Background-lavender-light, inner-content-contained, patient-support, section-no-margin
https://main--takeda-eds-sites-takhzyro--onetakeda.hlx.page/fragments/isi
Style
Inner-content-contained, section-no-margin
id
isi